NorthSea Therapeutics
is a Netherlands-based biotech company that develops novel drugs for the treatment of NASH, inflammatory and metabolic diseases... Read moreNorthSea Therapeutics
is a Netherlands-based biotech company that develops novel drugs for the treatment of NASH, inflammatory and metabolic diseases... Read more
News
Mar 06, 2025
FinanzNachrichten
NorthSea Therapeutics: NorthSea Therapeutics B.V.: NorthSea Therapeutics Announces Publication of Positive Results from Phase 2b ICONA Clinical Trial of Icosabutate in Biopsy-Confirmed F1-F3 MASH in Journal of Hepatology
Feb 20, 2025
FinanzNachrichten
NorthSea Therapeutics: NorthSea Therapeutics B.V.: NorthSea Therapeutics Announces Expansion of Leadership Team with Key Industry Veteran Hires
Feb 21, 2024
FinanzNachrichten
NorthSea Therapeutics: NorthSea Therapeutics B.V.: NorthSea Therapeutics Initiates Phase 2A Trial of Orziloben (NST-6179) in Intestinal Failure-Associated Liver Disease (IFALD)
Nov 10, 2023
FinanzNachrichten
NorthSea Therapeutics: NorthSea Therapeutics to Present ICONA Phase 2b Data as an Oral Late-breaker Session at the 2023 AASLD Liver Meeting
Oct 17, 2023
FinanzNachrichten
NorthSea Therapeutics: NorthSea Therapeutics B.V.: NorthSea Therapeutics Receives FDA Rare Pediatric Disease Designation for SEFA-6179 for the Treatment of Intestinal Failure-Associated Liver Disease
Jan 05, 2023
FinanzNachrichten
NorthSea Therapeutics: NorthSea Therapeutics B.V.: NorthSea Therapeutics Provides Clinical Update Reflecting Progress Across NASH And Metabolic Disorders Programmes
Feb 02, 2022
Clinical Trials Arena
NorthSea Therapeutics: NorthSea begins Phase I trial of liver disease asset in healthy volunteers
Dec 20, 2021
European Biotechnology
NorthSea Therapeutics: NorthSea Therapeutics completes US$80m Series C financing
Dec 17, 2021
Endpoints News
NorthSea Therapeutics: Biotech startup lines up more cash to steer its NASH drug through stormy seas
Dec 17, 2021
FirstWord PHARMA
NorthSea Therapeutics: NorthSea Therapeutics Completes US$80 Million Series C Fundraising to Advance Clinical Programs in Metabolic Disorders
NorthSea Therapeutics Competitors
1
2
3
4
5
6
7
8
9